Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases
IntroductionMinocycline can induce a rare but serious adverse drug reaction known as drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. We explored the clinical features of minocycline-associated DRESS to aid in early diagnosis and risk mitigation.MethodsA comprehensive explorat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1515000/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849317112802181120 |
|---|---|
| author | Yan Pan Qiquan Wu |
| author_facet | Yan Pan Qiquan Wu |
| author_sort | Yan Pan |
| collection | DOAJ |
| description | IntroductionMinocycline can induce a rare but serious adverse drug reaction known as drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. We explored the clinical features of minocycline-associated DRESS to aid in early diagnosis and risk mitigation.MethodsA comprehensive exploration of published cases from the start of electronic databases (PubMed, Embase, Web of Science, CNKI, Wanfang Data) to December 1, 2024. Cases were screened using RegiSCAR criteria.ResultsA total of 3,928 citations were identified through database searches, and after screening, 39 case reports (comprising 57 patients) were included. Fifty-seven patients (mean age 37.1 years) exhibited median DRESS onset at 17.5 days. Respiratory symptoms (87.7%, n = 50) dominated, including non-productive cough, dyspnea, pharyngitis, and wheezing. Fever occurred in 45 (78.9%) patients. Median eosinophilia peaked at 4.09 × 109/L. Symptom improvement median time was 10.5 days. Overall, forty-five patients (93.8% of 48 with outcome data) recovered post-minocycline discontinuation. Four deaths occurred (hepatic failure, refractory hypotension, unknown causes).ConclusionMinocycline-associated DRESS syndrome is characterized by diverse clinical manifestations, including prominent respiratory symptoms. Timely drug cessation, corticosteroid therapy, and vigilant monitoring are critical to optimize outcomes. These findings underscore the need for enhanced pharmacovigilance in high-risk populations. |
| format | Article |
| id | doaj-art-ff5815d31e9f4b29ae7c3adc19163881 |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-ff5815d31e9f4b29ae7c3adc191638812025-08-20T03:51:19ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-07-011610.3389/fphar.2025.15150001515000Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published casesYan Pan0Qiquan Wu1Department of Pharmacy, Fuda Cancer Hospital, Guangzhou, Guangdong, ChinaDepartment of Pharmacy, Ganzhou People’s Hospital, Ganzhou, ChinaIntroductionMinocycline can induce a rare but serious adverse drug reaction known as drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. We explored the clinical features of minocycline-associated DRESS to aid in early diagnosis and risk mitigation.MethodsA comprehensive exploration of published cases from the start of electronic databases (PubMed, Embase, Web of Science, CNKI, Wanfang Data) to December 1, 2024. Cases were screened using RegiSCAR criteria.ResultsA total of 3,928 citations were identified through database searches, and after screening, 39 case reports (comprising 57 patients) were included. Fifty-seven patients (mean age 37.1 years) exhibited median DRESS onset at 17.5 days. Respiratory symptoms (87.7%, n = 50) dominated, including non-productive cough, dyspnea, pharyngitis, and wheezing. Fever occurred in 45 (78.9%) patients. Median eosinophilia peaked at 4.09 × 109/L. Symptom improvement median time was 10.5 days. Overall, forty-five patients (93.8% of 48 with outcome data) recovered post-minocycline discontinuation. Four deaths occurred (hepatic failure, refractory hypotension, unknown causes).ConclusionMinocycline-associated DRESS syndrome is characterized by diverse clinical manifestations, including prominent respiratory symptoms. Timely drug cessation, corticosteroid therapy, and vigilant monitoring are critical to optimize outcomes. These findings underscore the need for enhanced pharmacovigilance in high-risk populations.https://www.frontiersin.org/articles/10.3389/fphar.2025.1515000/fullminocyclineeosinophiliahypersensitivitydressadverse event |
| spellingShingle | Yan Pan Qiquan Wu Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases Frontiers in Pharmacology minocycline eosinophilia hypersensitivity dress adverse event |
| title | Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases |
| title_full | Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases |
| title_fullStr | Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases |
| title_full_unstemmed | Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases |
| title_short | Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases |
| title_sort | clinical manifestations diagnostic criteria and treatment outcomes of minocycline associated dress syndrome a comprehensive exploration of published cases |
| topic | minocycline eosinophilia hypersensitivity dress adverse event |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1515000/full |
| work_keys_str_mv | AT yanpan clinicalmanifestationsdiagnosticcriteriaandtreatmentoutcomesofminocyclineassociateddresssyndromeacomprehensiveexplorationofpublishedcases AT qiquanwu clinicalmanifestationsdiagnosticcriteriaandtreatmentoutcomesofminocyclineassociateddresssyndromeacomprehensiveexplorationofpublishedcases |